, therapeutic approaches that target both diseases are needed.
Clinical trials are currently underway to explore
Gareev, Ilgiz,
Aamir, Ahmad,
Jiaqi, Wang,
Aferin, Beilerli,
Tatiana, Ilyasova,
Albert, Sufianov,
Ozal, Beylerli (2023) in this pathology determine its extremely
high
clinical and social significance. Diagnosis and timely treatment
. Moreover, we address the challenges of translating these findings into
clinical applications, including
СИНДРОМ ХАДЧЕНСОНА-ГИЛФОРДА (ПРОГЕРИЯ), and various
clinical manifestations. As a result of the research, the most effective methods of diagnosing
Beylerli, Ozal,
Tamrazov, Rasim,
Gareev, Ilgiz,
Ilyasova, Tatiana,
Shumadalova, Alina,
Bai, Yunlong,
Yang, Baofeng (2023) and future
perspectives of using exosomal ncRNAs as
clinical tools for TBI management. © 2023 The Authors